Foxo Technologies Inc. (FOXO) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Total · absolute moveSwitch to Alpha · OTC
Foxo Technologies Inc. (FOXO) stock forecast summary
Our AI ranks Foxo Technologies Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Its market capitalization is not available, so no size classification is given.
A per-ticker accuracy statistic for FOXO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, FOXO included.
Follow FOXO freeFOXO price chart and AI forecast
How FOXO ranks among 4009 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Foxo Technologies Inc. (FOXO) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Commercial Physical & Biological Research peers listed below that report each metric.
Financial Health
| Metric | FOXO | Rank |
|---|---|---|
| Current Ratio | 0.12x | 13/16 |
| Quick Ratio | 0.11x | 6/6 |
| Interest Coverage | 6.7x | 3/13 |
| Working Capital | -$36M | 12/15 |
Cash Flow
| Metric | FOXO | Rank |
|---|---|---|
| Operating Cash Flow | -$5M | 9/15 |
Income Statement
| Metric | FOXO | Rank |
|---|---|---|
| Operating Income | $8M | 6/15 |
| R&D Expense | $180K | 7/7 |
| SG&A Expense | $11M | 10/12 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $5M | |
| Cash & Short-term Investments | $60K | |
| Accounts Receivable | $4M | |
| Inventory | $160K | |
| Short-term Debt | $33M |
FOXO quarterly financials and insider trading
Foxo Technologies Inc. (FOXO) industry peers
Companies classified under the same SEC industry code as Foxo Technologies Inc. (Services-Commercial Physical & Biological Research): 16 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| FOXO Foxo Technologies Inc. | ▼ | N/A |
| IQV Iqvia Holdings Inc. | ▼ | $43.51B |
| INCY Incyte Corp | ▼ | $21.70B |
| MEDP Medpace Holdings, Inc. | ▶ | $17.02B |
| CRL Charles River Laboratories International, Inc. | ▶ | $14.27B |
| ICLR Icon Plc | ▶ | $12.68B |
| ABSI Absci Corp | ▲ | $1.56B |
| OABI Omniab, Inc. | ▲ | $683M |
| NRC Nrc Health | ▲ | $446M |
| MXCT Maxcyte, Inc. | ▲ | $100M |
| ONMD Onemednet Corp | ▶ | $24M |
| VSBC Vitaspring Biomedical Co. Ltd. | ▼ | $7M |
| BUDZ Weed, Inc. | ▶ | $3M |
| BIAF Bioaffinity Technologies, Inc. | ▼ | N/A |
| CBIH Cannabis Bioscience International Holdings, Inc. | ▼ | N/A |
| ISPC Ispecimen Inc. | ▼ | N/A |
Where FOXO sits on the market map
Foxo Technologies Inc. (FOXO) stock news
Loading...
Foxo Technologies Inc. (FOXO) stock forecast FAQ
What is the Foxo Technologies Inc. (FOXO) stock forecast?
Our AI ranks Foxo Technologies Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Foxo Technologies Inc. stock predictions?
A per-ticker accuracy statistic for FOXO is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Foxo Technologies Inc. forecasts updated?
Foxo Technologies Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Foxo Technologies Inc.'s industry peers?
16 issuers in our coverage, FOXO included, share the SEC industry code Services-Commercial Physical & Biological Research. The largest are: Iqvia Holdings Inc. (IQV), Incyte Corp (INCY), Medpace Holdings, Inc. (MEDP), Charles River Laboratories International, Inc. (CRL), Icon Plc (ICLR), Absci Corp (ABSI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.